Resources for Medicare Beneficiaries: Navigating the Coverage Gap | How the Gap May Affect You
This six-page brochure helps Medicare Part D recipients and caregivers better understand the Medicare coverage gap, often referred to as the “donut hole.” During the “donut hole,” Medicare temporarily stops paying for prescriptions and recipients must pay the entire costs of the medicines by themselves. This brochure explains:
- Who may be affected by the coverage gap;
- How the coverage gap works; and
- How to track covered drug expenses (a sample expense log is provided).
A Spanish version of this brochure also is available (2009).
E.V.I.dently May 2013
Message From NPCThe Role of Pharmaceuticals in Health Insurance ExchangesOne of the most pressing issues in the implementation of the Affordable Care...
CER Tweets of the Week (Apr. 22-26, 2013)
A plan by the Patient-Centered Outcomes Research Institute (PCORI) to allocate $68 million to develop a network of research centers was widely...A Look at Rx Coverage and Cost in the New Health Insurance Exchanges
National Pharmaceutical Chief Science Officer Dr. Robert Dubois will lead a panel discussion, "Capturing the Value of Pharmaceuticals--A Look at Rx...NPC Welcomes Dr. Bryan Luce as PCORI Chief Science Officer
The National Pharmaceutical Council today welcomed the news that the Patient-Centered Outcomes Research Institute (PCORI) has appointed its first...
Study Quantifies Impact of Pharmaceuticals on Enhanced Productivity
(WASHINGTON, DC, August 1, 2012)–The costs to employers of chronic health conditions on employee productivity are well documented, but few studies...New Survey Shows Employers Eyeing CER, PCORI for Health Information
Washington, DC, June 22, 2011--Employers are aware of comparative effectiveness research (CER) and its potential to answer critical questions about...New Report Urges Employers, Researchers and Policy Makers to Rethink How They Measure Health Care Results
San Francisco, CA & Washington, DC (February 28, 2011) -- Understanding the full value of improved health, including improvements in workforce...NBCH eValue8™ Report Reveals Health Plans’ Ability to Align Employee Incentives to Improve Health
Washington, DC (November 30, 2009) – The current rate of health care cost increases are unsustainable and health care purchasers are increasingly...
What Will 2011 Hold for CER and PCORI?
When future historians consider health care, they may well look back on 2010 as a watershed year in America. The issues and events that occurred last...NPC Reflects on Changes in 2010
It’s been a year of great change not only for the biopharmaceutical industry, but for the National Pharmaceutical Council as well. With these changes...A Look at Value-Based Insurance Design
This month, NPC released a new report, “Value-Based Insurance Design Landscape Digest,” focusing on an important approach being used by leading edge...Congress Looks at Public vs. Public-Private CER Entity
As part of the ongoing congressional health care reform debate, there are several competing proposals regarding the creation of a comparative...
How Do Payers Consider Individual Treatment Effects?
Dr. Robert Epstein, former chief medical officer and senior vice president of medical affairs at Medco Health, explains that heterogeneity, or...Comparative Effectiveness Research in Medicare Decision-Making
At the June 2011 Drug Information Association Annual Meeting, NPC asked Dr. Marcel Salive for his thoughts on how comparative effectiveness research...IBI's Tom Parry on Employers and Health Investments
Integrated Benefits Institute President Tom Parry, PhD, sat down with NPC to discuss how employers today are defining the value of their health...Value-Based Insurance Design
National Pharmaceutical Council President Dan Leonard discusses a new report on Value-Based Insurance Design (VBID) with Dr. A. Mark Fendrick, Co-...CER Tweets of the Week (Apr. 22-26, 2013)
A plan by the Patient-Centered Outcomes Research Institute (PCORI) to allocate $68 million to develop a network of research centers was widely...A Look at Rx Coverage and Cost in the New Health Insurance Exchanges
National Pharmaceutical Chief Science Officer Dr. Robert Dubois will lead a panel discussion, "Capturing the Value of Pharmaceuticals--A Look at Rx...NPC Welcomes Dr. Bryan Luce as PCORI Chief Science Officer
The National Pharmaceutical Council today welcomed the news that the Patient-Centered Outcomes Research Institute (PCORI) has appointed its first...Accountable Care Organizations: Framework for Biopharmaceuticals
NPC Chief Science Officer Dr. Robert Dubois today will moderate a panel discussion, "Accountable Care Organization (ACO) Framework for...Research
Growth in Use of Lipid-Lowering Therapies: Are We Targeting the Right Patients?
Within the context of concerns over growing prescrip
- 1 of 12
- >
Commentary & Testimony
What Will 2011 Hold for CER and PCORI?
NPC Reflects on Changes in 2010
A Look at Value-Based Insurance Design
Congress Looks at Public vs. Public-Private CER Entity
NPC Submits Testimony on Draft CER Definition, Criteria and Framework